ÖZBAŞ, B. Et Al. 2023. Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.23, no.5 , 721-726.

ÖZBAŞ, B., DEMİR, M., DURSUN, H., Sahin, I., HACIOĞLU, A., ÖZDAMAR KARACA, Z. C., ... DÜNDAR, M.(2023). Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.23, no.5, 721-726.

ÖZBAŞ, BURAK Et Al. "Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient," ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.23, no.5, 721-726, 2023

ÖZBAŞ, BURAK Et Al. "Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.23, no.5, pp.721-726, 2023

ÖZBAŞ, B. Et Al. (2023) . "Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.23, no.5, pp.721-726.

@article{article, author={BURAK ÖZBAŞ Et Al. }, title={Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient}, journal={ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS}, year=2023, pages={721-726} }